Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 349241 - 349260 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (B02BD04) coagulation factor ix | Idelvion 500 IE | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 500 IE , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Hemophilia B | CSLBehringGmbH(2) |
| Norway | (B02BD04) coagulation factor ix | Refixia 500 IE | , sett, Pulver og væske til injeksjonsvæske, oppløsning, 500 IE , sett | Retail price with vat |
$0-0 |
$0-0 |
Hemophilia B | NovoNordiskA/S(2) |
| Norway | (B02BD04) coagulation factor ix | Immunine 600 IE | , Hetteglass, Pulver og væske til injeksjons-/infusjonsvæske, oppløsning, 600 IE , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | BaxaltaInnovationsGmbH |
| Norway | (B02BX05) eltrombopag (adm: O) | Revolade 25 mg | 30 x 1 stk, Dosepose, Pulver til mikstur, suspensjon, 25 mg , Dosepose | Retail price with vat |
$0-0 |
$0-0 |
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic | NovartisEuropharmLimited |
| Norway | (B02BX05) eltrombopag (adm: O) | Revolade 25 mg | 28 stk, Blisterpakning, Tablett, filmdrasjert, 25 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic | NovartisEuropharmLimited |
| Norway | (B02BX05) eltrombopag (adm: O) | Revolade 25 mg | 14 stk, Blisterpakning, Tablett, filmdrasjert, 25 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic | NovartisEuropharmLimited |
| Norway | (B02BX05) eltrombopag (adm: O) | Revolade 50 mg | 28 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic | NovartisEuropharmLimited |
| Norway | (B02BX05) eltrombopag (adm: O) | Revolade 50 mg | 14 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic | NovartisEuropharmLimited |
| Norway | (B02BX05) eltrombopag (adm: O) | Revolade 75 mg | 14 stk, Blisterpakning, Tablett, filmdrasjert, 75 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic | NovartisEuropharmLimited |
| Norway | (B02BX06) emicizumab (adm: P) | Hemlibra 150 mg/ml | 0.7 ml, Hetteglass, Injeksjonsvæske, oppløsning, 150 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Hemophilia A | RocheRegistrationGmbH |
| Norway | (B02BX06) emicizumab (adm: P) | Hemlibra 150 mg/ml | 1 ml, Hetteglass, Injeksjonsvæske, oppløsning, 150 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Hemophilia A | RocheRegistrationGmbH |
| Norway | (B02BX06) emicizumab (adm: P) | Hemlibra 150 mg/ml | 0.4 ml, Hetteglass, Injeksjonsvæske, oppløsning, 150 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Hemophilia A | RocheRegistrationGmbH |
| Norway | (B02BX06) emicizumab (adm: P) | Hemlibra 30 mg/ml | 1 ml, Hetteglass, Injeksjonsvæske, oppløsning, 30 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Hemophilia A | RocheRegistrationGmbH |
| Norway | (B05ZB) hemofiltrates | Cifoban 136 mmol/L | 8 x 1500 ml, Pose, Infusjonsvæske, oppløsning, 136 mmol/L , Pose | Retail price with vat |
$0-0 |
$0-0 |
n/a | FreseniusMedicalCareDeutschlandGmbH |
| Norway | (B06AC01) c1-inhibitor, plasma derived (adm: P) | Berinert 2 000 IU | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 2 000 IU , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | CSLBehringGmbH(2) |
| Norway | (B06AC01) c1-inhibitor, plasma derived (adm: P) | Berinert 3 000 IU | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 3 000 IU , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | CSLBehringGmbH(2) |
| Norway | (B06AC01) c1-inhibitor, plasma derived (adm: P) | Berinert 1 500 IU | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 1 500 IU , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | CSLBehringGmbH(2) |
| Norway | (B06AC01) c1-inhibitor, plasma derived (adm: P) | Berinert 500 IU | , Hetteglass, Pulver og væske til injeksjons-/infusjonsvæske, oppløsning, 500 IU , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | CSLBehringGmbH |
| Norway | (B06AC01) c1-inhibitor, plasma derived (adm: P) | Cinryze 500 IE | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 500 IE , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Angioedemas, Hereditary | TakedaManufacturingAustriaAG |
| Norway | (B06AC06) berotralstat (adm: O) | Orladeyo 150 mg | 28 stk, Blisterpakning, Kapsel, hard, 150 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Angioedemas, Hereditary | BioCrystIrelandLimited |
Pages
